Skip to content
healthcare.dev
Get a free key

New Stock Fungi Mix

NDC 22840-9651, Acremonium strictum, Alternaria alternata, Aspergillus niger, Aureobasidium pullulans, Bipolaris sorokiniana, Botrytis cinerea, Candida albicans, Chaetomium globosum, Cladosporium sphaerospermum, Epicoccum nigrum, Gibberella fujikuroi, Mucor plumbeus, Penicillium notatum, Phoma betae, Rhizopus stolonifer and Trichophyton mentagrophytes, solution, from Greer Laboratories, Inc..

Product NDC
22840-9651
Status
Listed
Labeler
Greer Laboratories, Inc.
Dosage form
SOLUTION
Route
INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
Product type
NON-STANDARDIZED ALLERGENIC
Marketing category
BLA
Application
BLA101833
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/22840-9651 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PLEOSPORA BETAE1250 [PNU]/mL
  • COCHLIOBOLUS SATIVUS1250 [PNU]/mL
  • CANDIDA ALBICANS1250 [PNU]/mL
  • CHAETOMIUM GLOBOSUM1250 [PNU]/mL
  • RHIZOPUS STOLONIFER1250 [PNU]/mL
  • TRICHOPHYTON MENTAGROPHYTES1250 [PNU]/mL
  • ASPERGILLUS NIGER VAR. NIGER1250 [PNU]/mL
  • AUREOBASIDIUM PULLULANS VAR. PULLUTANS1250 [PNU]/mL
  • EPICOCCUM NIGRUM1250 [PNU]/mL
  • GIBBERELLA FUJIKUROI1250 [PNU]/mL
  • MUCOR PLUMBEUS1250 [PNU]/mL
  • ALTERNARIA ALTERNATA1250 [PNU]/mL
  • ACREMONIUM STRICTUM1250 [PNU]/mL
  • BOTRYTIS CINEREA1250 [PNU]/mL
  • CLADOSPORIUM SPHAEROSPERMUM1250 [PNU]/mL
  • PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM1250 [PNU]/mL

Pharmacologic classes

Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]

Package NDCNDC-11Package
22840-9651-22284096510210 mL in 1 VIAL, MULTI-DOSE (22840-9651-2)
22840-9651-42284096510450 mL in 1 VIAL, MULTI-DOSE (22840-9651-4)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 22840-9651 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/22840-9651 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 22840-9651. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.